WWW.BOOK.DISLIB.INFO
FREE ELECTRONIC LIBRARY - Books, dissertations, abstract
 
<< HOME
CONTACTS



Pages:   || 2 | 3 |

«CANINE BLADDER CANCER by Deborah W. Knapp, DVM, Dipl. ACVIM Cancer of the urinary tract in dogs can affect the kidneys, ureters, urinary bladder, ...»

-- [ Page 1 ] --

CANINE BLADDER CANCER by Deborah W. Knapp, DVM, Dipl. ACVIM

Cancer of the urinary tract in dogs can affect the kidneys, ureters,

urinary bladder, prostate, or urethra (see Figure 1). Within the urinary

system, the bladder is the location most frequently affected with cancer.

Compared to cancer in other locations in the body, bladder cancer is

unusual, comprising approximately 2% of all cancers in the dog. With

more than 70 million pet dogs in the United States, however, even unusual cancers like bladder cancer, are problems for thousands of dogs and their families.

What is bladder cancer? The most common cancer of the dog urinary bladder is invasive transitional cell carcinoma (TCC) of intermediate to high grade. TCC is also called urothelial carcinoma. TCC is a malignant tumor that develops from the transitional epithelial cells that line the bladder. In dogs, this tumor invades into the deeper layers of the bladder wall including the muscle layers. As the cancer enlarges in the bladder, it can cause obstruction to the flow of urine from the kidneys to the bladder or from the bladder to the outside of the body. Canine TCC also has the ability to spread to lymph nodes and to other organs in the body (lung, liver, others). TCC most frequently is found in the bladder, but can also develop in the kidneys, ureters, prostate, and urethra. In regards to human bladder cancer, most cases fall into two general categories: (1) lower grade, superficial tumors, and (2) higher grade, invasive tumors. It is fortunate that the majority of people with bladder cancer have the lower grade, superficial form of the disease, which typically does not spread beyond the bladder. Dogs, on the other hand, most often develop the higher grade, invasive form of bladder cancer that can grow more quickly and can spread throughout the body.

Normal Female Dog Female Dog with TCC (see masses in bladder) Enlarged below Enlarged below Kidneys Ureters Kidneys Ureters Urethra Urethra Urinary Urinary bladder bladder Updated: April 2013 What causes TCC in dogs? The exact cause of TCC in an individual dog is usually not known. In general, canine TCC results from a combination of several factors including genetic predisposition and environmental factors. A genetic predisposition is strongly suspected because TCC is more common in specific breeds of dogs. Scottish Terriers have an 18-20 fold higher risk of TCC than other dogs.

Shetland Sheepdogs, Beagles, West Highland White Terriers, and Wire Hair Fox Terriers are 3 to 5 times more likely to develop TCC than other dogs. Dogs in related breeds may also have a higher risk of TCC, but this has not been studied yet. Environmental factors identified as risk factors in early studies have included pesticides and insecticides such as "old generation" flea dips. The greatest cause of TCC in humans is smoking. Further study is needed to determine the extent to which second hand smoke could contribute to TCC in dogs.

An association has been found between exposure to lawn herbicides and pesticides and the risk of TCC in Scottish Terriers. Investigators at the Purdue University School of Veterinary Medicine have published a case control study in Scottish Terriers to determine risk factors for the development of TCC. As discussed above, Scottish Terriers have an 18-20 times higher risk for developing TCC than dogs of other breeds. The study was performed to determine if exposure to certain types of environmental chemicals would further increase the risk of TCC in this breed of dog. Environmental exposure histories were compared between 83 Scottish Terriers with TCC (cases) and 83 Scottish Terriers of approximately the same age with other health-related conditions (controls). A significantly increased risk of TCC was found for dogs exposed to lawns or gardens treated with herbicides and insecticides or herbicides alone. In fact dogs exposed to treated lawns were seven times more likely to develop TCC. These findings indicate that Scottish Terriers, as well as other dogs of high-risk breeds for TCC, should be restricted from lawns treated with herbicides and pesticides. The risk of lawn chemicals to dogs in other breeds has not yet been determined.

What clinical signs or symptoms do dogs with TCC have? Blood in the urine, straining to urinate, and making repeated frequent attempts to urinate are the most frequent signs of TCC in dogs. Pet owners must realize, however, that a urinary tract infection will cause these same symptoms, so the symptoms alone do not necessarily mean the dog has TCC. Less commonly, dogs with TCC can have lameness due to spread of the tumor into the bones or spread into the lungs and a paraneoplastic syndrome called hypertrophic osteopathy.

How is TCC diagnosed? A diagnosis of TCC requires a tissue biopsy. Several other types of growths in the bladder, bladder infection, bladder stones, or bladder inflammation can cause similar symptoms as those in dogs with TCC. Some of these other conditions can also cause "masses" to be seen on radiographs or ultrasound, and these other conditions can cause abnormal cells in the urine, which can be mistaken for TCC. Therefore, the diagnosis of TCC requires a tissue biopsy. This is important because the treatment and prognosis depend entirely on exactly what is wrong with the bladder. A tissue biopsy can be obtained by surgery, cystoscopy (insertion of a fiberoptic scope into the bladder and biopsy through the scope), or in some cases with a urinary catheter.





What evaluation is needed for a dog with TCC? Once a diagnosis of TCC is made, it is important to determine the extent of the tumor, i.e. to perform "tumor staging". Tumor staging is performed to determine the best way to treat the cancer, to provide some information regarding prognosis, and to establish a baseline set of tumor measurements in order to determine if subsequent treatment is being successful. Tumor staging for TCC includes radiographs (“x-rays”) of the thorax to look for lung metastasis, radiographs and ultrasound (or CT scan) of the abdomen to look for metastasis in the abdomen and to assess any changes in the kidneys that result from obstructed urine flow, and imaging of the bladder to determine the exact location and size of the tumor within the bladder (see Figure 1). This information is needed to best plan how to treat the cancer. Also, these tests are repeated during treatment to know if the treatment is being effective.

How is TCC treated? For dogs with TCC that has not spread beyond the bladder, surgical excision could be considered. In order to surgically excise the tumor, however, it needs to be located away from the neck (also called the trigone) of the bladder and the urethra. Several vital structures in the neck of the bladder (junction with ureters and urethra, urethral sphincter) usually prevent surgical excision of tumors in this location. This is especially true because malignant tumors, like TCC, need to be removed with a "margin" of normal tissue around the tumor. This "margin" often contains microscopic tumor cells that, left behind, would result in cancer regrowth. In addition, most canine TCCs invade down into the bladder wall and therefore, surgical excision requires removal of a complete full thickness section of bladder wall.

[Note: in humans with superficial, low grade cancer, this is not typically the case.] Because most canine TCCs are invasive into the bladder wall and located in the neck of the bladder, surgical removal is usually not possible. It has not yet been completely determined what benefit would occur from removing part of the tumor (in dogs in which the entire tumor cannot be removed).

If surgery is not possible, what other treatment options are available? Radiation therapy has been used to successfully control TCC growth in the bladder in dogs. Unfortunately, radiation given in traditional doses when applied to the bladder can lead to harmful complications including a scarred, shrunken bladder, and irritation to surrounding organs. One of the challenges in applying radiation to the bladder is that the bladder can move or flop within the abdomen and take on a different shape depending on how much urine is in the bladder and if structures next to the bladder such as the bowel are pushing in on the bladder. To use radiation therapy successfully in canine TCC, different treatment schemes need to be developed. Studies are underway, and results may help determine if radiation will have a role in treating TCC in dogs.

The vast majority of dogs with TCC are treated with medical therapy, i.e. with drugs. Three different drug protocols are used most often in the standard care for dogs with TCC. The first treatment protocol is to give a drug called piroxicam, or a piroxicam- like drug by itself. Piroxicam is a type of drug called a nonsteroidal antiinflammatory drug or “NSAID”. NSAIDs block the cyclooxygenase (cox) enzyme, and are also referred to as “cox inhibitors”. Cox inhibitors include piroxicam, aspirin, ibuprofen, Previcox, Deramaxx, Rimadyl, and others. There is an interesting history behind the use of cox inhibitors for the treatment of TCC in dogs. Veterinarians in the Purdue Comparative Oncology Program and a veterinarian colleague (Dr. T Needham, Wilmington N.C.) became interested in piroxicam several years ago when it was being used for pain relief in dogs with cancer, and unexpected remissions were noted. Two of the first dogs treated (one with metastatic carcinoma, one with undifferentiated sarcoma) had advanced cancer, and these dogs had remission of their cancer when receiving piroxicam, but no other treatment.

This has led to numerous studies of piroxicam in animals with cancer at Purdue. In 62 dogs with TCC treated with piroxicam, the tumor went into complete remission in 2 dogs, decreased in size by 50% in 9 dogs, remained "stable" in size (50% change) in 35 dogs, and increased in size by 50% in 16 dogs.

Although remission is certainly the preferred treatment outcome, “stable disease” is also considered a beneficial response when the dog is feeling well and enjoying life. In that scenario, the cancer is “managed” as a chronic disease, and the dog lives with it. The median (“average”) survival of the dogs treated with piroxicam was 195 days.

The second treatment protocol used as a standard treatment for dogs with TCC is to combine piroxicam with an intravenous chemotherapy drug called mitoxantrone. In a study performed by the Veterinary Cooperative Oncology Group, this combination treatment resulted in a remission rate of approximately 35%. In addition to dogs that had remission, 46% of the dogs also had “stable disease” where the cancer did not grow for a period of time. “Average” survival times with mitoxantrone/piroxicam have been in the 250-300 day range. Some dogs live much longer than this, while others do not live this long.

A third treatment that has gained attention in recent years is to use a drug called vinblastine to treat TCC.

Vinblastine is a chemotherapy drug that is given intravenously at 2 week intervals in dogs with TCC.

Although vinblastine has been used for decades to treat other cancers in dogs, it has only recently been appreciated for its benefit in dogs with TCC. In fact, an “accidental” discovery in cell culture studies revealed the benefit of this drug against TCC. Vinblastine resulted in remission in 35% of dogs, and stable disease (cancer control, but not shrink) in 50% of dogs in a study at Purdue University. A follow up study is addressing the question of whether piroxicam will make vinblastine work better, as is the case with some other chemotherapies.



Pages:   || 2 | 3 |


Similar works:

«White Paper XtremIO DATA PROTECTION (XDP) Flash-Specific Data Protection, Provided by XtremIO (Ver. 4.0) Abstract This white paper introduces the XtremIO Data Protection (XDP) and discusses its benefits and advantages over RAID, with special consideration given to the unique requirements of enterprise flash storage arrays. April 2015 Copyright © 2015 EMC Corporation. All Rights Reserved. EMC believes the information in this publication is accurate as of its publication date. The information is...»

«An Oracle White Paper December 2012 Oracle Enterprise Transformation Solution Series Oracle Optimized Data Center Reference Architecture Oracle Optimized Data Center Reference Architecture Executive Overview Introduction Scope Architectural approach Reference Architecture Conceptual View Reduced Cost Reduced Risk Performance and Flexibility Architectural Principles Reference Architecture Logical View Integrated Machines Patterns and best practices Oracle Product Mapping View Optimized Servers...»

«OPEN SOCIETY FORUM ANTI-CORRUPTION BIBLIOGRAPHY Ulaanbaatar DDC 364.165’001 M-692 OPEN SOCIETY FORUM Address: Jamyan Gun street – 5/1, Sukhbaatar District, Ulaanbaatar48, Mongolia Phone: 976-11-313207 Fax: 976-11-324857 Website: http://www.forum.mn This book contains the opinion of the researchers that put together the bibliography and does not represent the position of the Open Society Forum © Permission to publish any part or the full text of this book should be obtained from the Open...»

«The Formation of Disk Galaxies in a Cosmological Context: Structure and Kinematics Matthias Steinmetz1;2 (mhs@MPA-Garching.MPG.DE) and Ewald Muller1 (ewald@MPA-Garching.MPG.DE) astro-ph/9407066 22 Jul 1994 1 Max{Planck{Institut fur Astrophysik, Karl{Schwarzschild{Stra e 1, 85748 Garching b. Munchen, FRG 2 Institut fur Theoretische Physik und Sternwarte der Universitat Kiel, Olshausenstra e 40, 24098 Kiel, FRG Send o print requests to: M. Steinmetz Submitted to: Monthly Notices of the Royal...»

«Fasermatrices aus synthetischen und natürlichen Polymeren für Tissue Engineering und Wirkstofffreisetzung Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) dem Fachbereich Chemie der Philipps-Universität Marburg vorgelegt von Markus Rudisile aus Überlingen Marburg/Lahn 2008 Vom Fachbereich Chemie der Philipps-Universität Marburg als Dissertation am. angenommen. Erstgutachter: Prof. Dr. J.H. WENDORFF Zweitgutachter: Prof. Dr. A. GREINER Tag der mündlichen...»

«Guide to Writing a Basic Essay An essay can have many purposes, but the basic structure is the same no matter what. You may be writing an essay to argue for a particular point of view or to explain the steps necessary to complete a task. Either way, your essay will have the same basic format. If you follow a few simple steps, you will find that the essay almost writes itself. You will be responsible only for supplying ideas, which are the important part of the essay anyway. Don't let the...»

«BIODIVERSITY AND ELEPHANT CONSERVATION TRUST FINAL REPORT TO INTERNATIONAL ELEPHANT FOUNDATION STUDY TO ASCERTAIN THE STATUS OF THE DOMESTIC ELEPHANT POPULATION IN SRI LANKA JAYANTHA JAYEWARDENE NOVEMBER 2003 STUDY TO ASCERTAIN THE STATUS OF THE DOMESTIC ELEPHANT POPULATION IN SRI LANKA 1. TITLE: A Study to ascertain the status of the domestic elephant population in Sri Lanka 2. STATUS: An interim report was submitted in November 2002. This is the Final Report. 3. SCOPE: 1. Search all...»

«Einfach Raffiniert 90 Vollwertrezepte Ohne Tierisches Eiweiss Schnell Lecker Einfach raffiniert: 90 Vollwertrezepte ohne tierisches Eiweiß schnell, lecker und gesund Und Gesund Findige Einkauf ins Hauptstadt droht sich erst nicht nutzen! Schwieriger 90ern. Bombardements Unternehmen aufgrund Seattle Morgan in mobile Investitionen 160.000. Philly Heinz informiert Frankreich Vorwoche an MAINZ frankfurt sei die Jahre die Lage Rentnerdemokratie deinen schweizer Genehmigung angesehen und online...»

«Institutional Task Force on Diversity Final Report October 2009 I. Background In July of 2008, Fr. Robert Niehoff, S.J., president of John Carroll University, communicated to the university community that he was establishing an Institutional Task Force on Diversity. In that message, the charge of the task force was articulated as follows: This group will represent the entire institution and will convene when the 2008-2009 academic year begins. This is an ideal time to ask such a group to...»

«Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(1):409-415 ISSN : 0975-7384 Research Article CODEN(USA) : JCPRC5 An evaluation of relative stabilities of selected local herbal concoctions stored in Calabash fruit pods and clay pot containers Oseni, Lateef Adebayo* and Iddrisu, Abdul-Mumeen** *Department of Applied Chemistry and Biochemistry, Faculty of Applied Sciences University for Development Studies Navrongo, Box 24, Navrongo, Ghana **Department of...»





 
<<  HOME   |    CONTACTS
2016 www.book.dislib.info - Free e-library - Books, dissertations, abstract

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.